Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
BIOTECH GROWTH N V buys 1,740,000 shares of Black Diamond Therapeutics, Inc. [BDTX]
By USInMinutes - Jun 29, 2023, 02:38 PM ET
Last Updated - Jul 18, 2023, 03:06 PM EDT
![BIOTECH GROWTH N V buys 1,740,000 shares of Black Diamond Therapeutics, Inc. [BDTX]](/_next/image?url=https%3A%2F%2F10k-staging.s3.us-west-2.amazonaws.com%2Fnews_images%2Farticle_Black%2520Diamond%2520Therapeutics%252C%2520Inc_20233829180635354.%2520%255BBDTX%255D&w=3840&q=75)
Transaction increases the holding of BIOTECH GROWTH N V in the company to 7,117,839
Biotech Growth N V has bought 1,740,000 shares of Black Diamond Therapeutics, Inc. [BDTX] at $5.49 a share.
Black Diamond Therapeutics, Inc. [BDTX] disclosed in an SEC Form 4 submission Tuesday, June 27, 2023 that the deal increased Biotech Growth N V's holding in the company to 7,117,839.
Black Diamond Therapeutics, Inc. [BDTX] is a Biological Products, Except Diagnostic Substances company based in Delaware.
Also Read:
- Black Diamond Therapeutics to Present at the Jefferies Healthcare Conference
- Black Diamond Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate ...
- Black Diamond Therapeutics to Present at the Stifel 2023 Targeted Oncology Days
- Black Diamond Therapeutics Presents Trial in Progress Poster for BDTX-1535 and Preclinical Data ...
- Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and ...
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Although all care is taken to ensure the accuracy of the data, the article does not intend to replace user diligence while taking decisions of financial or legal implications.
Sponsored
Read More from USinMinutes
Popular News
Latest News
